Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +41,016 41,016
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +122,601 122,601
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +13,671 13,671
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +13,671 13,671
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +50,712 91,728
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +3,394 17,065
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +3,394 17,065
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +21,695 113,423
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +1,452 18,517
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion +1,452 18,517
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −41,016 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −122,601 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −13,671 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series A Preferred Stock −13,671 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-1 Preferred Stock −50,712 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-1 Preferred Stock −3,394 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-1 Preferred Stock −3,394 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-2 Preferred Stock −21,695 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-2 Preferred Stock −1,452 0
2020-10-20 BLATT LAWRENCE Chief Executive Officer Conversion · Series B-2 Preferred Stock −1,452 0

Page 11 of 12 · 238 trades